‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Š National Institute of Health Sciences
¶•¨–ò•i•” Division of Biological Chemistry and Biologicals
@@@
yrINNzgevokizumab (List 66, 2011, Vol.25, No. 3, p314)
ypINNzgevokizumab (List 104, 2010, Vol.24, No. 4, p373)

y‰ðài˜a–ójz
IgG2ƒÈ, RƒqƒgIL1B(ƒCƒ“ƒ^[ƒƒCƒLƒ“1ƒÀ, 1L1F2CIL-1Bj, ƒqƒg‰»ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì; ƒCƒ“ƒ^[ƒƒCƒLƒ“-1ƒÀhR–òD
H½ (ƒÁ2½C1-445)F[humanized VH (Homo sapiens IGHV2-5*10(72.70%)-(IGHD)-IGHJ5*01) [10.7.12] (1-120) -Homo sapiens IGHG2*02 CH3 K130>del(121-445)]D
L½ (ƒÈ½C1'-214')F[humanized V-KAPPA (Homo sapiens IGKV1-39*01(82.10%)-IGKJ1*01 V124>L(104')) [6.3.9] (1'-107') -Homo sapiens IGKC*01 (108'-214')]D
ƒWƒXƒ‹ƒtƒBƒhŒ‹‡‚̈ʒuF134-214', 222-222''C223-223'', 226-226''C229-229''
“œ½•t‰ÁˆÊ’uF296, 296''

y•ªŽqŽ®z

yCAS”Ô†z1129435-60-4

yJANzŒfÚ‚È‚µ
Copyright (C) @@@Division of Biological Chemistry and Biologicals@@@All rights reserved.